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ПРИМЕНЕНИЕ ОЗОНА В ЛЕЧЕНИИ  
ГНОЙНО-ВОСПАЛИТЕЛЬНЫХ ОСЛОЖНЕНИЙ  
БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ
Резюме. Применение озонотерапии в комплексном лечении больных 
сахарным диабетом с гнойно-воспалительными процесами, оказывает выраженное 
лечебное действие и предотвращает развитие рецидива и осложнений заболевания, 
что способствует значительному улучшению непосредственных и отдаленных 
результатов лечения данной патологии.
Ключевые слова: сахарный диабет, гнойно-воспалительные осложнения, 
озонотерапия.
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Abstract. In a complex treatment ozone application of patients with diabetes compli-
cated by pyoinflammatory processes has an apparent therapeutic effect and prevents the devel-
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opment of the relapse and complications of the disease promoting significant improvements of 
direct and remote results of treatment of the given pathology.
Key words: diabetes mellitus, pyoinflammatory processes, lipid peroxydation, ozo-
notherapy.
Introduction. Scientific data analysis shows a steady increase in the number of 
patients with diabetes, and in developed countries reaches more than 6% of the population 
[2, 5].
From the surgical point of view, topicality of this problem is first of all stipulated by 
the fact that purulent-necrotic processes develop in more than 30-70% diabetic patients and 
50% of hospitalized patients need surgical care concerning these complications [1, 3, 4].
With regard of to the mentioned facts, it becomes evident that the effective meth-
ods of complex treatment of purulent processes in diabetic patients should be searched in 
order to introduce into clinical practice the effective methods of conservative treatment and 
new ways of reparative processes activation. For this purpose ozonotherapy has recently 
become widely used.
The aim of research to improve the treatment results of pyoinflammatory pro-
cesses in patients with diabetes through the use of intravenous ozonotherapy.
Material and method. 124 diabetic patients with pyoinflammatory complications 
have been examined. The main group  – 53 (42.7%) patients, along with comprehensive 
treatment underwent intravenous ozone therapy. The control group -71 (57.2%) patients 
were treated by conventional methods.
Intravenous administration of ozonized physiological solution was performed in 
all patients of the main group, along with traditional therapy, similar in composition to 




Coagulogram characteristics in diabetic mellitus patients with pyoinflammatory complications 
using ozonotherapy
Indices





















Recalcification time (s) 105 ±0,9 100±0,7 98±1,1 110±0,8 105±1,1 99±0,7


























  Р >0,05 ≤0,001 ≤0,001 >0,05 ≤0,001 ≤0,001
Note: Р – index of statistical significance
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According to some authors, in diabetic patients with pyoinflammatory lesion of 
soft tissues the level of lipid peroxidation end product – malonic aldehyde in the wound 
increases. Inhibition of AOP manifests by a significant decrease in tissue retinol and tocoph-
erol in particular, as well as decreased activity of glutathione reductase. The most effective 
treatment methods in terms of lipid peroxidation stabilization are those including ultravio-
let blood irradiation, low-intensity laser irradiation and sorbents application [2, 6].
Hypercoagulation syndrome vith microthromboses development and whieh is 
manifested by is pathognomonic an increased thrombocytes aggregation activity. Combined 
with decreased anticoagulant and fibrinolytic blood activity it stipulates the widespread use 
of reocorrectors together with anticoagulants and antiaggregants [6].
The results of the coagulogram study in diabetic patients with pyoinflammatory com-
plications (Table 1) showed that in the control group of patients on admission, during the 
treatment and at discharge significant changes were not detected concerning to the prothrom-
bin index, recalcification time, thrombin time, hematocrit, and fibrinogen. In the context of 
ozone therapy application in the main group of patients on admission, during the treatment 
and at discharge the significant coagulogram parameters changes were not revealed.
These changes against a background of typical positive clinical effects of ozone 
therapy can be regarded as a favourable signs of coagulogram parameters for the application 
of this method of treatment in diabetic patients with pyoinflammatory complications.
The analysis of lipid peroxidation indices, AOP, OPM parameters in diabetic pa-
tients with pyoinflammatory complications (Table 2) showed that in the control group of 
patients on admission, during the treatment and at discharge significant changes were not 
detected as to the activity of AOP factor – ceruloplasmin, lipid peroxidation product – ma-
lonic aldehyde and OPM. In the context of ozone therapy application in the main group 
of patients on admission, during the treatment and at discharge the parameters were not 
considerably changed either.
In our opinion the coagulogram parameters, lipid peroxidation, AOP, OPM indices 
against the background of typical positive clinical effects of ozone therapy application can 
be regarded as favorable biochemical signs for the use of the given method of treatment in 
diabetic patients with pyoinflammatory complications.
Table 2 
Characteristics of lipid peroxidation, AOP, OPM parameters in diabetic patients with 
pyoinflammatory complications
Indices













Ceruloplasmin (Е/g of 
plasm)
5,2±0,10 5,1±0,30 5,1±0,10 5,3±0,30 5,5±0,7 5,5±0,50
Malonic aldehyde 
(micromole/l of serum)
0,23±0,10 0,24±0,05 0,20±0,10 0,22±0,10 0,23±0,10 0,19±0,10
Degree of oxidative 
modification of proteins 
(∆Е/ml of plasm)
2,2±0,05 2,2±0,04 2,0±0,06 1,5±0,05 1,4±0,03 1,6±0,04
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Conclusions:
1. Implementation of the positive effects of ozone therapy in the clinic in diabetic pa-
tients with pyoinflammatory complications is not accompanied by the development of damage 
reactions on the level of hemostasis parameters and blood biochemical parameters.
2. The above mentioned fact confirms the expediency of intravenous ozone therapy 
application clinically in this category of patients.
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